Patent details

EP2178888 Title: PROTEASOME INHIBITORS

Basic Information

Publication number:
EP2178888
PCT Application Number:
PCT/US/2007/017440
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP078110871
PCT Publication Number:
WO/2009/020448
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PROTEASOME INHIBITORS
French Title of Invention:
INHIBITEURS DE PROTÉASOMES
German Title of Invention:
PROTEASOMINHIBITOREN
SPC Number:
LUC00013

Dates

Filing date:
06/08/2007
Grant date:
04/07/2012
EP Publication Date:
04/07/2012
PCT Publication Date:
12/02/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/04/2010
EP B1 Publication Date:
04/07/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
06/08/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/11/2022
 
 

Name:
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Address:
1-1, Doshomachi 4-chome Chuo-ku, 540-8645, Osaka, Japan (JP)

History of Owners

From:
06/08/2007
To:
18/11/2022

Name:
Millennium Pharmaceuticals Inc.
Address:
40 Landsdowne Street, Cambridge, MA 02139, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
16/08/2012
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
OLHAVA Edward, J.
Address:
United States (US)

2

Name:
DANCA Miheala, D.
Address:
United States (US)

Classification

Main IPC Class:
C07F 5/02;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2022/13
Publication date:
01/12/2022
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20220000463A
Date Registered:
18/11/2022
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Address:
1-1, Doshomachi 4-chome Chuo-ku, 540-8645, Osaka, Japan (JP)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
31/08/2026
Annual Fee Number:
20
Annual Fee Amount:
300 Euro
Expected Payer:
Last Annual Fee Payment Date:
23/07/2025
Last Annual Fee Paid Number:
19
Last Annual Fee Paid Amount:
281 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
18/11/2022 Request For Change 9
18/11/2022 Outgoing Correspondence 1